Diurnal Variation in Glucose Tolerance: Cyclic Suppression of Insulin Action and Insulin Secretion in Normal-Weight, But Not Obese, Subjects

The relative roles of insulin sensitivity, insulin secretion, and glucose effectiveness to the diurnal rhythm of glucose tolerance were examined in normal-weight (n = 12) and obese (n = 11) subjects. Two frequently sampled intravenous glucose tolerance tests were performed in each subject at 0800 on one occasion and 1800 on a separate day. Tests were preceded by identical fasts of 10–12 h. In nonobese subjects, glucose tolerance, expressed as the 10- to 16-min KG value (KGS), was much reduced in the evening (AM 2.98 ± 0.45, PM 1.86 ± 0.33 min−1 P < 0.002). In the obese subjects, tolerance was lower in the morning than normal-weight subjects (2.19 ± 0.31 min−1), but unlike in nonobese subjects, tolerance was not significantly reduced during the day (1.90 ± 0.18 min−1 P > 0.40). The reduction in glucose tolerance in the normal-weight subjects was caused by diminished insulin sensitivity (parameter S1, AM 15.4 ± 2.9, PM 10.2 ± 1.9 × 10−5 min−1/pM, P < 0.01) and reduced β-cell responsivity to glucose. The evening decrease in the latter was reflected both in first-phase plasma insulin (AM 2466 ± 441, PM 1825 ± 381 pM/10 min, P < 0.05) and the potentiation slope (AM 462 ± 68, PM 267 ± 35 pM/mM, P < 0.01). In contrast, consistent with no diurnal variation in glucose tolerance, obese subjects exhibited no decline in insulin sensitivity in the evening (AM 3.6 ± 0.7, PM 4.9 ± 1.0 × 10−5 min−1/pM). A marginally significant decline in (β-cell responsiveness was observed in the obese group (potentiation slope AM 388 ± 78, PM 233 ± 58 pM/mM, P < 0.05). Glucose tolerance is maintained when the pancreas adequately compensates for prevailing insulin resistance, a relationship described by the disposition index (SI, × Φ1). This product decreased 46% in nonobese subjects from morning to evening (P < 0.05), reflecting the inability of the pancreas to overcome prevailing insulin resistance, and resulting in evening glucose intolerance. No diurnal decline in the disposition index was observed in obese subjects. The diurnal rhythms in insulin sensitivity and secretion in nonobese subjects are not consistent with known rhythms in growth hormone or cortisol, but could be due to the effects of a putative diurnal rhythm of sympathetic activity, which would suppress both insulin sensitivity and secretion in the evening. The absence of a rhythm in the obese could reflect an autonomic or hormonal dysfunction that may be related to body-weight regulation.

[1]  R N Bergman,et al.  Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. , 1987, The Journal of clinical investigation.

[2]  Y. Z. Ider,et al.  Quantitative estimation of insulin sensitivity. , 1979, The American journal of physiology.

[3]  P. Bennett,et al.  The natural history of impaired glucose tolerance in the Pima Indians. , 1988, The New England journal of medicine.

[4]  R N Bergman,et al.  Insulin sensitivity and B‐cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes , 1991, American journal of obstetrics and gynecology.

[5]  R N Bergman,et al.  Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. , 1990, The Journal of clinical endocrinology and metabolism.

[6]  R. Jarrett,et al.  Diurnal variation in insulin sensitivity. , 1972, Lancet.

[7]  L. Mandarino,et al.  Effects of Growth Hormone on Insulin Action in Man: Mechanisms of Insulin Resistance, Impaired Suppression of Glucose Production, and Impaired Stimulation of Glucose Utilization , 1982, Diabetes.

[8]  S. Sensi Some aspects of circadian variations of carbohydrate metabolism and related hormones in man. , 1974, Chronobiologia.

[9]  J. Halter,et al.  Relationship of islet function to insulin action in human obesity. , 1987, The Journal of clinical endocrinology and metabolism.

[10]  H. Keen,et al.  Diurnal Variation in Response to Intravenous Glucose* , 1974, British medical journal.

[11]  J. Gagliardino,et al.  Circadian Variation of the Blood Glucose, Plasma Insulin and Human Growth Hormone Levels in Response to an Oral Glucose Load in Normal Subjects , 1974, Diabetes.

[12]  J. Olefsky,et al.  Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. , 1980, The Journal of clinical investigation.

[13]  G. Di Chiara,et al.  Differential roles of splanchnic and peripheral tissues in determining diurnal fluctuation of glucose tolerance. , 1989, The American journal of physiology.

[14]  J. Roth,et al.  PLASMA INSULIN AND GROWTH HORMONE LEVELS IN OBESITY AND DIABETES , 1965, Annals of the New York Academy of Sciences.

[15]  J. A. Scarlett,et al.  Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. , 1982, The American journal of physiology.

[16]  H. Keen,et al.  Further Observations on the Diurnal Variation in Oral Glucose Tolerance , 1970, British medical journal.

[17]  R N Bergman,et al.  MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. , 1986, Computer methods and programs in biomedicine.

[18]  R. Boston,et al.  Effects of epinephrine infusion on determinants of intravenous glucose tolerance in dogs. , 1988, The American journal of physiology.

[19]  R N Bergman,et al.  Importance of Glucose Per Se to Intravenous Glucose Tolerance: Comparison of the Minimal-Model Prediction with Direct Measurements , 1985, Diabetes.

[20]  L. Mandarino,et al.  Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. , 1982, The Journal of clinical endocrinology and metabolism.

[21]  T F Gallagher,et al.  Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. , 1971, The Journal of clinical endocrinology and metabolism.

[22]  D. Wilmore,et al.  Combined Hormonal Infusion Simulates the Metabolic Response to Injury , 1984, Annals of surgery.

[23]  L. Mandarino,et al.  Rates of noninsulin-mediated glucose uptake are elevated in type II diabetic subjects. , 1985, The Journal of clinical investigation.

[24]  R. Jarrett,et al.  Diurnal variation in the blood-sugar and plasma-insulin response to tolbutamide. , 1972, Lancet.

[25]  Klaus P. Ratzmann Dr. Insulin resistance in man , 2004, Diabetologia.

[26]  A. Lazarow,et al.  Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic Rats , 1963, Diabetes.

[27]  G. Reaven,et al.  Effect of time on measurement of hepatic glucose production. , 1988, The Journal of clinical endocrinology and metabolism.

[28]  R. Bergman Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach , 1989, Diabetes.

[29]  R J Jarrett,et al.  Diurnal Variation in Oral Glucose Tolerance: Blood Sugar and Plasma Insulin Levels Morning, Afternoon, and Evening , 1972, British medical journal.

[30]  P. Nestel,et al.  Diurnal Variation in Glucose Tolerance and in Insulin Secretion in Man , 1973, Diabetes.

[31]  G. Reaven Role of Insulin Resistance in Human Disease , 1988, Diabetes.